colforsin has been researched along with Cognition Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A; Singh, N | 1 |
| Farchi, N; Hochner, B; Shoham, S; Soreq, H | 1 |
| Albasanz, JL; Barrachina, M; Ferrer, I; MartÃn, M; Perez-Buira, S; Rodriguez, A | 1 |
3 other study(ies) available for colforsin and Cognition Disorders
| Article | Year |
|---|---|
Calcineurin Inhibition and Protein Kinase A Activation Limits Cognitive Dysfunction and Histopathological Damage in a Model of Dementia of the Alzheimer's Type.
Topics: Acetylcholinesterase; Aging; Alzheimer Disease; Animals; Brain; Calcineurin; Calcineurin Inhibitors; Cholinesterase Inhibitors; Cognition Disorders; Colforsin; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Donepezil; Drug Therapy, Combination; Female; Glutathione; Male; Maze Learning; Mice; Peroxidase; Streptozocin; Tacrolimus; Thiobarbituric Acid Reactive Substances; Vasodilator Agents | 2018 |
Impaired hippocampal plasticity and errors in cognitive performance in mice with maladaptive AChE splice site selection.
Topics: Acetylcholinesterase; Alternative Splicing; Animals; Carbachol; Choice Behavior; Cholinergic Agonists; Cholinesterase Inhibitors; Cognition Disorders; Colforsin; Dose-Response Relationship, Radiation; Electric Stimulation; Excitatory Postsynaptic Potentials; Female; In Vitro Techniques; Long-Term Potentiation; Male; Maze Learning; Mice; Mice, Transgenic; Neuronal Plasticity; Physostigmine; Protein Kinase C; Protein Kinase C beta | 2007 |
Expression levels of adenosine receptors in hippocampus and frontal cortex in argyrophilic grain disease.
Topics: Adenosine A1 Receptor Agonists; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Aged; Aged, 80 and over; Cadaver; Cognition Disorders; Colforsin; Dementia; Female; Frontal Lobe; Hippocampus; Humans; Male; Middle Aged; Phenylalanine; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Purinergic P1; Silver Staining; Tauopathies | 2007 |